SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-135583
Filing Date
2020-05-07
Accepted
2020-05-07 07:21:03
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d897672d10q.htm 10-Q 746094
2 EX-31.1 d897672dex311.htm EX-31.1 6801
3 EX-31.2 d897672dex312.htm EX-31.2 6788
4 EX-32.1 d897672dex321.htm EX-32.1 4395
5 EX-32.2 d897672dex322.htm EX-32.2 4310
  Complete submission text file 0001193125-20-135583.txt   4250840

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20200331.xml EX-101.INS 876984
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20200331.xsd EX-101.SCH 42846
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20200331_cal.xml EX-101.CAL 33868
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20200331_def.xml EX-101.DEF 193869
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20200331_lab.xml EX-101.LAB 361625
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20200331_pre.xml EX-101.PRE 289631
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 20854562
SIC: 2834 Pharmaceutical Preparations